+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hair Loss Treatment Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

  • ID: 5328028
  • Report
  • January 2021
  • Region: Global
  • Coherent Market Insights Pvt Ltd.

FEATURED COMPANIES

  • Aurobindo Pharma
  • Cipla Limited
  • Daiichi-Sankyo Co., Ltd.
  • Dr. Reddy’s Laboratories
  • Follica, Inc.
  • HCell Inc.
Hair loss is a common condition and it can be caused by numerous disorders. Hair loss or alopecia begins after the onset of puberty. Pattern or androgenetic alopecia is a genetically predetermined disorder due to excessive response to androgens that affects around 50% of males and females globally, according to the National Center for Biotechnology Information (NCBI). It is characterized by progressive loss of terminal hair of the scalp, in a characteristic distribution in both males and females. In males, hair loss is most prominent in the vertex and frontotemporal regions, while in women the frontal hairline is typically spared with diffuse apical hair loss noted as a wider anterior part of the hair.

Market Dynamics

Rising incidence of androgenetic alopecia is expected to drive the global hair loss treatment market growth. For instance, according to the National Library of Medicine (NLM), a medical library, which is part of the National Institutes of Health (NIH), androgenetic alopecia affects around 50 million men and 30 million women in the U.S.

However, availability of alternative treatments is expected to hinder the market growth. For instance, hair restoration surgery such as scalp reduction surgeries, which is not used frequently but efficacy of hair transplantation is based on the principle of donor dominance.

Key features of the study:
  • This report provides in-depth analysis of the global hair loss treatment market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global hair loss treatment market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study are Viviscal, Cipla Limited, Aclaris Therapeutics, Inc., Merck & Co., Inc., Daiichi-Sankyo Co., Ltd., Johnson and Johnson Services, Inc., Lexington International LLC, Vita-Cos-Med Klett-Loch GmbH, PureTech, Vitabiotics, Dr. Reddy’s Laboratories, Ranbaxy Laboratories Ltd, HCell Inc., Follica, Inc., Aurobindo Pharma, and Zydus Pharmaceuticals, Inc. (Zydus Cadila), among others
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
  • The global hair loss treatment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hair loss treatment market.
Detailed Segmentation:

Global Hair Loss Treatment Market, By Type:
  • Noncicatricial
  • Telogen Effluvium
  • Androgenetic Alopecia
  • Alopecia Areata
  • Cicatricial
  • Others
Global Hair Loss Treatment Market, By Product Type:
  • Corticosteroids
  • Antihypertensives
  • Topical Immune-modulators
  • Others
Global Hair Loss Treatment Market, By Route of Administration:
  • Oral
  • Topical
Global Hair Loss Treatment Market, By Gender:
  • Male
  • Female
Global Hair Loss Treatment Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Global Hair Loss Treatment Market, By Region:
  • North America
  • By Country
  • U.S.
  • Canada
  • Latin America
  • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Country/Region
  • South Africa
  • Central Africa
  • North Africa
Company Profiles
  • Viviscal*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Highlights
  • Market Strategies
  • Cipla Limited
  • Aclaris Therapeutics, Inc.
  • Merck & Co., Inc.
  • Daiichi-Sankyo Co., Ltd.
  • Johnson and Johnson Services, Inc.
  • Lexington International LLC
  • Vita-Cos-Med Klett-Loch GmbH
  • PureTech
  • Vitabiotics
  • Dr. Reddy’s Laboratories
  • Ranbaxy Laboratories Ltd
  • HCell Inc.
  • Follica, Inc.
  • Aurobindo Pharma
  • Zydus Pharmaceuticals, Inc. (Zydus Cadila).
“*” marked represents similar segmentation in other categories in the respective section.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aurobindo Pharma
  • Cipla Limited
  • Daiichi-Sankyo Co., Ltd.
  • Dr. Reddy’s Laboratories
  • Follica, Inc.
  • HCell Inc.
1. Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations
2. Market Purview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snippet, By Type
  • Market Snippet, By Product Type
  • Market Snippet, By Route of Administration
  • Market Snippet, By Gender
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
  • Opportunity Map
3. Market Dynamics, Regulations, and Trends Analysis
  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Pipeline Analysis
  • Reimbursement Scenario
  • Epidemiology
  • Pest Analysis
  • Regulatory Scenario
  • New Product Launches
  • Collaborations and Agreements
  • Market Trends
4. Global Hair Loss Treatment Market - Impact of Coronavirus (COVID-19) Pandemic
  • COVID-19 Market Scenario
  • Impact of COVID-19 Market on the Hair Loss Treatment Products
5. Global Hair Loss Treatment Market, By Type, 2016-2027, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017 - 2027
  • Segment Trends
  • Noncicatricial
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
  • Telogen Effluvium
  • Androgenetic Alopecia
  • Alopecia Areata
  • Cicatricial
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
6. Global Hair Loss Treatment Market, By Product Type, 2016-2027, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017 - 2027
  • Segment Trends
  • Corticosteroids
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
  • Antihypertensive
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
  • Topical Immune-modulators
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
7. Global Hair Loss Treatment Market, By Route of Administration, 2016-2027, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017 - 2027
  • Segment Trends
  • Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
  • Topical
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
8. Global Hair Loss Treatment Market, By Gender, 2016-2027, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017 - 2027
  • Segment Trends
  • Male
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
  • Female
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
9. Global Hair Loss Treatment Market, By Distribution Channel, 2016-2027, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017 - 2027
  • Segment Trends
  • Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
  • Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
  • Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
10. Global Hair Loss Treatment Market, By Region, 2016-2027, (US$ Mn)
  • Introduction
  • Market Share Analysis, By Region, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2027
  • North America
  • Market Size and Forecast, By Type, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Product Type, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Gender, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027, (US$ Mn)
  • U.S.
  • Canada
  • Latin America
  • Market Size and Forecast, By Type, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Product Type, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Gender, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Market Size and Forecast, By Type, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Product Type, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Gender, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027, (US$ Mn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Market Size and Forecast, By Type, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Product Type, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Gender, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027, (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • Market Size and Forecast, By Type, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Product Type, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Gender, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • Market Size and Forecast, By Type, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Product Type, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Gender, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Country/Region, 2016-2027, (US$ Mn)
  • South Africa
  • Central Africa
  • North Africa
11. Competitive Landscape
  • Heat Map Analysis
  • Market Share Analysis
  • Viviscal
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Cipla Limited
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Aclaris Therapeutics, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Merck & Co., Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Daiichi-Sankyo Co., Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Johnson and Johnson Services, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Lexington International LLC
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Vita-Cos-Med Klett-Loch GmbH
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • PureTech
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Vitabiotics
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Dr. Reddy’s Laboratories
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Ranbaxy Laboratories Ltd
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • HCell Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Follica, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Aurobindo Pharma
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Zydus Pharmaceuticals, Inc. (Zydus Cadila)
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Analyst Views
12. Section
  • References
  • Research Methodology
  • About us and Sales Contact
Note: Product cover images may vary from those shown
  • Viviscal
  • Cipla Limited
  • Aclaris Therapeutics, Inc.
  • Merck & Co., Inc.
  • Daiichi-Sankyo Co., Ltd.
  • Johnson and Johnson Services, Inc.
  • Lexington International LLC
  • Vita-Cos-Med Klett-Loch GmbH
  • PureTech
  • Vitabiotics
  • Dr. Reddy’s Laboratories
  • Ranbaxy Laboratories Ltd
  • HCell Inc.
  • Follica, Inc.
  • Aurobindo Pharma
  • Zydus Pharmaceuticals, Inc. (Zydus Cadila).
Note: Product cover images may vary from those shown
Adroll
adroll